BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8163653)

  • 1. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.
    Perombelon YF; Soutar AK; Knight BL
    J Clin Invest; 1994 Apr; 93(4):1481-92. PubMed ID: 8163653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration.
    Prins J; Leus FR; Bouma BN; van Rijn HJ
    Thromb Haemost; 1999 Dec; 82(6):1709-17. PubMed ID: 10613659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
    Rader DJ; Cain W; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1993 Feb; 91(2):443-7. PubMed ID: 8432853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein Lp(a): effects of allelic variation at the LPA locus.
    Rainwater DL; Kammerer CM
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):54-61. PubMed ID: 9723166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
    Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
    Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels.
    Falcó C; Estellés A; Dalmau J; España F; Aznar J
    Thromb Haemost; 1998 Apr; 79(4):818-23. PubMed ID: 9580386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
    van der Hoek YY; Lingenhel A; Kraft HG; Defesche JC; Kastelein JJ; Utermann G
    J Clin Invest; 1997 May; 99(9):2269-73. PubMed ID: 9151801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1995; 12(2):129-43. PubMed ID: 7607414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) in homozygous familial hypercholesterolemia.
    Kraft HG; Lingenhel A; Raal FJ; Hohenegger M; Utermann G
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):522-8. PubMed ID: 10669652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
    J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect.
    Gaw A; Brown EA; Ford I
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1870-6. PubMed ID: 9848878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians.
    Valenti K; Aveynier E; Leauté S; Laporte F; Hadjian AJ
    Atherosclerosis; 1999 Nov; 147(1):17-24. PubMed ID: 10525120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
    Peros E; Geroldi D; D'Angelo A; Falcone C; Montagna L; Carabela M; Emanuele E
    Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
    Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.